Gul Dolen — Psychedelic Critical Periods
Founder: Gul Dolen, PhD
Headquarters: Baltimore, Maryland
Website: https://dolenlab.org
Category: Science & Research
About the Channel
Gul Dolen is a Johns Hopkins neuroscientist whose research on critical period reopening has become one of the most cited mechanistic frameworks for understanding how psychedelics produce lasting change. Her lab's discovery that MDMA reopens the critical period for social reward learning — published in Nature — has spawned a new research direction examining whether psilocybin and other psychedelics similarly reopen developmental critical periods that normally close in adulthood. The critical period hypothesis provides a developmental neuroscience explanation for why psychedelics can achieve what years of conventional therapy cannot: they may temporarily restore the brain's exceptional plasticity from early development. Dolen's public talks and interviews explain this research in accessible terms for general audiences.
Editorial Context
Dolen's critical period hypothesis is the most mechanistically coherent explanation for why psychedelic effects last so much longer than the acute drug experience. It connects psychedelic pharmacology to developmental neuroscience in a way that expands the therapeutic hypothesis and suggests specific clinical implications. Essential for anyone who wants to understand the neuroscience beyond the REBUS model.
Key Topics
- critical period reopening by MDMA
- social reward learning in adolescence vs adulthood
- implications for psychedelic-assisted therapy timing
- comparison of psychedelics for critical period reopening
- what happens in the brain during the integration window